Erbitux in combination with radiation therapy is indicated for the treatment of patients with locally. advanced squamous cell cancer of the head and neck. This indication is now revised as follows (new in bold): Erbitux is indicated for the treatment of patients with squamous cell cancer of the head and neck. • in combination with radiation therapy for locally advanced disease. • in combination with platinum-based chemotherapy for recurrent and/or metastatic disease. 2 Clinical aspects.